Skip to content
← Myelodysplastic Syndromes

FOR PATIENTS · SOURCE READING

Treatment of Relapsed or Refractory Myelodysplastic Syndromes

Source: Myelodysplastic Syndromes Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: October 4, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

For information about the treatments listed below, see the Treatment Option Overview section.

Source links and citations

There is no standard treatment for refractory or relapsed myelodysplastic syndromes. Patients whose cancer does not respond to treatment or has come back after treatment may want to take part in a clinical trial.

Source links and citations

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice